SKI Market

A+| A| A-|

Indian Indices

Sensex

76,015.28 -1,312.91
( -1.70%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,457.26 -256.39
(-0.41%)

Nikkei 225

10,269.73 36.66
(0.36%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540025

INE837H01020

59.9554673

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ADVENZYMES

32.45

3999.14

EPS(TTM)

Face Value()

Div & Yield %

11.01

1.46

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	351.41	365.47	311.53	272.80	283.47	247.35
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	351.41	365.47	311.53	272.80	283.47	247.35
Other Income	61.49	58.81	9.81	9.08	6.82	9.00
Stock Adjustments	6.47	7.83	-1.48	13.52	-1.27	5.68
Total Income	419.37	432.11	319.86	295.40	289.02	262.03
EXPENDITURE :
Raw Materials	148.80	139.56	121.43	112.72	95.03	94.44
Power & Fuel Cost	18.52	22.73	19.58	16.19	11.53	10.95
Employee Cost	56.04	49.39	41.42	39.32	34.23	32.61
Other Manufacturing Expenses	19.94	18.57	14.52	13.53	9.25	9.08
Selling & Administrative Expenses	38.39	33.64	32.37	28.66	28.58	25.74
Miscellaneous Expenses	5.25	22.95	5.64	3.08	2.81	3.26
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	286.93	286.83	234.97	213.49	181.44	176.08
Operating Profit	132.44	145.28	84.89	81.90	107.58	85.96
Interest	0.51	0.39	0.33	0.27	0.22	1.29
Gross Profit	131.93	144.89	84.56	81.63	107.36	84.67
Depreciation	11.41	10.90	10.28	9.56	8.93	8.81
Profit Before Tax	120.52	133.99	74.28	72.07	98.43	75.86
Tax	16.89	26.95	18.25	18.02	24.84	19.39
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.22	-1.08	0.50	-0.46	2.57	-1.49
Reported Net Profit	102.42	108.12	55.53	54.51	71.01	57.96
Extraordinary Items	0.05	-15.13	-0.59	0.89	0.51	0.00
Adjusted Net Profit	102.37	123.25	56.12	53.62	70.50	57.96
Adjustment below Net Profit	-0.34	-0.10	0.49	0.02	-0.03	-1.31
P & L Balance brought forward	469.61	417.50	372.66	328.19	263.91	213.96
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	57.03	55.91	11.18	10.06	6.70	6.70
P & L Balance carried down	514.66	469.61	417.50	372.66	328.19	263.91
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	260.00	255.00	50.00	50.00	45.00	30.00
Dividend Per Share(Rs)	5.20	5.10	1.00	1.00	0.90	0.60
Earnings Per Share-Unit Curr	9.15	9.67	4.97	4.88	6.36	5.19
Earnings Per Share(Adj)-Unit Curr	9.15	9.67	4.97	4.88	6.36	5.19
Book Value-Unit Curr	56.25	51.91	46.98	42.97	38.97	33.17
Book Value(Adj)-Unit Curr	56.25	51.91	46.98	42.97	38.97	33.17

76,015.28 -1,312.91 ( -1.70%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,457.26 -256.39 (-0.41%)

10,269.73 36.66 (0.36%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)